bma-2025
12th -
13th
March 2025 | 
Marina Bay Sands Expo & Convention Centre, Singapore

Map The Future of Asia's Bioprocessing Sector

12th -
13th
March 2025 | 
Marina Bay Sands Expo & Convention Centre, Singapore
📆 Add to Google Calendar
0 +
Attendees
0 +
Organizations
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies

The 12th Annual Biologics Manufacturing Asia 2025 is Asia’s bioprocessing-focused, knowledge-sharing conference that provides regional biopharmaceutical industry stakeholders a carefully tailored networking platform for leveraging opportunities for strategic collaboration, and exposure to the latest manufacturing technologies and know-how.

We have an agenda built around success stories from Asia’s biopharmas as well as the technical expertise from International Biopharmas and BIG Pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, facility design, and scale-up strategy, fill & finish innovation to streamline the operations amongst other crucial themes.

The BMA 2025 is co-located with 9th Annual Biologistics World Asia 2025, 3rd Clinical Trial Festival Asia 2025 and Asia-Pacific Bioprocessing Excellence Awards Gala Dinner 2025.

Biologics Manufacturing Asia 2025

Explore the most comprehensive upstream processing from early cell isolation and cultivation, cell line engineering, media development, raw materials considerations and more for enhancing and optimizing cell culture return and production rate with cost-reduction strategy. Know-how on the latest development of upstream processing technologies have evolved and potentially changed the biologics drug manufacturing process to be more economically feasible.

Immerse into the most focused biologics downstream processing with the ultimate goal of meeting quality and purity requirements of biologics drug products. Multiple purification approaches, concentration, product recovery, cost reduction and optimizing the integration of continuous manufacturing and utilization of single use disposable systems to optimize biologics manufacturing process production rate will be discussed.

Innovative strategy of assay optimization, real time monitoring system with highest compromisation to quality control of biologics products to a direction of improving efficiency while advocating process automation are the keys to quicker market commercialization and regulatory compliance. Topics built around cost and process optimization with latest developments in analytics and quality to foster biologics enhancement.

Understand the challenges and the trends of biomanufacturing facility design in detail and find out the best practices of formulation and bulk technology transfer for optimizing output while maintaining quality and activity of products. Emphasis on scaling up processes without compromising product quality while discussing the latest technology and solution to scale up for maximum output.

Identify the most imminent trends on the emerging technologies and applications with the potential to enhance and fasten the biologics manufacturing process. Applications such as PAT tools, novel technologies in single-use technologies and continuous processing, as well as automation and bioprocessing 4.0 to fasten the biologics manufacturing process will be discussed.

THANK YOU TO OUR SPONSORS









Biologics Manufacturing Asia 2025

Advisory Board

Amish_Patel-250x250

Amish A. Patel

SVP Technical Operations

Calidi Biotherapeutics
USA
Bakulesh-Khamar

Bakulesh Khamar

Executive Director,

Cadila Pharmaceuticals,
India
Jean-Francois-Dierick_photo_profile

Jean-François Dierick

Strategic Analytical Validation & Lifecycle Lead

GSK
Belgium
Wei-Kuang-Chi_photo_profile-1

Wei-Kuang Chi

Chief Strategy Officer

Taiwan Bio-Manufacturing Corporation
Taiwan

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Akira-Kurabayashi_photo_profile-3

Akira Kurabayashi

Head of Digital & Engineering Dept.,

Chugai Pharma Manufacturing
Japan
Andreas Castan, PhD

Andreas Castan

PhD, Strategic Technology Leader

Cytiva
Sweden
Ashutosh Kumar

Ashutosh Kumar

Professor, Structural Biology, Department of Biosciences and Bioengineering

Indian Institute of Technology Bombay
India
badar copy

Badarulhisam Abdul Rahman

Chief Scientific Officer,

Pharmaniaga Research Centre
Malaysia
Xue_Zhi_Bi

Bi Xuezhi

Associate Professor, Senior Principal Scientist and Group Leader, Analytical Science & Technologies (Protein Analytics)

BTI – A*Star
Singapore
Chester-Drum_photo_profile-3

Chester Drum

Associate Professor

National University of Singapore
Singapore
Denis-Feshin_photo_profile

Denis Feshin

Sr. Application Researcher,

Avantor
Korea
img

Felicitas Guth

Head of Development Pharma Solutions,

BASF SE
Germany
Gary-Khoo_photo_profile

Gary Khoo

VP of Chemistry, Manufacturing & Controls (CMC),

Hummingbird Bioscience
Singapore
Hem-Reddy_photo_profile-3

Hem Reddy

Director of APAC Business Development,

Pfanstiehl Inc.
USA
Jianbing-Zhao

Jianbing Zhao

Downstream Head of BioPharma China,

Boehringer Ingelheim
China
Jimmy-Li

Jimmy Li

Chief Executive Officer,

WuXi XDC
China
Judy-Chou_photo_profile-3

Judy Chou

President and Chief Executive Officer,

AltruBio
USA
Kai-Yin-Po_photo_profile

Kai Yin Po

Associate Principal Scientist, Regulatory Affairs - CMC,

MSD
Singapore
Kibret_Mequanint

Kibret Mequanint

Professor, Department of Chemical and Biochemical, Engineering, School of Biomedical Engineering,

University of Western Ontario
Canada
Kishore-Kumar

Kishore Kumar

Deputy General Manager

Intas Pharmaceuticals
India
MicrosoftTeams-image (34)

Klaus Köhler

Global Industry Manager, Life Sciences

Endress+Hauser
Germany
KwangJun-Yoon_photo_profile

KwangJun Yoon

Managing Director

Matica BIOLABS
South Korea
Leon-Cruz_photo_profile-3

Leon Cruz

Head of Production,

Duopharma
Malaysia 
Luca-Alberici_photo_profile

Luca Alberici

General Manager,

AGC Biologics
Milan
Maarten-Pennings

Maarten Pennings

Chief Technology Officer

BiosanaPharma, Leiden
The Netherlands
Matt-Lowe_photo_profile

Matt Lowe

Chief Strategy Officer,

Master Control
USA
MicrosoftTeams-image (35)

Nattha Ingavat

Senior Scientist I, Biologics Downstream Processing & Characterization

A*STAR Bioprocessing Technology Institute (BTI)
Singapore
Niki-Wong_photo_profile

Niki Wong – Keynote

Director, Global Technical Operations, CMC,

AbbVie
Singapore
Parthasarathy_Biocon

Parthasarathy Sampath Kumar

Head Center of Operational Excellence - Group COE

Biocon
India
Prateek-Gupta_photo_profile

Prateek Gupta

VP and Head, Process Development & MSAT,

Stelis Biopharma
India
Prateek Joshi

Prateek Joshi

Global Product Manager

Sartorius Stedim Biotech GmbH
Goettingen
Qin-Gang

Qin Gang

President

GeneQuantum Healthcare
China
Rajkumar-Gaikwad_photo_profile

Rajkumar Gaikwad

Director Bioengineering,

Truking Technology Limited,
India
Ravi-Ganapathy_photo_profile

Ravi Ganapathy

Director, R&D CMC

Hilleman Laboratories
Singapore
Rubin-Jiang_photo_profile

Rubin Jiang

Director of Antibody Process Development & MSAT

GenScript ProBio
China
Seat-Yee-Lau_photo_profile-3

Seat Yee Lau

Director Process Development

Amgen Singapore Manufacturing
Singapore
Senali-Abayratna-Wansa

Senali Abayratna Wansa

Head of Analytical Development, Development Services

LONZA Biologics
Singapore
Shireen_CRF_Photo (1) 1

Shireen Goh

Principal Scientist , Group Leader of Biomanufacturing Devices

A*STAR Bioprocessing Technology Institute
Singapore
Tiju Thomas

Tiju Thomas

APAC Bioprocess Applications Head

3M
Singapore
Vipul-Doshi_photo_profile

Vipul Doshi

President - Group Quality Assurance and Regulatory,

Zydus Lifesciences
India
Weichang-Zhou

Weichang Zhou

President of Global Biologics Development and Operations & Chief Technology Officer

WuXi Biologics
Wolfram-Carius_photo_profile

Wolfram Carius – Keynote

Executive Vice President of Cell and Gene Therapy, Pharmaceuticals Division,

Bayer Pharmaceuticals
Germany
Yan Xiaojun

Yan Xiaojun

Chief Technology Officer

CytoNiche
China
Yaron-Silberberg_photo_profile

Yaron Silberberg

Ph.D., Chief Scientist & Head of Customer Solution Center

Ajinomoto CELLiST Korea
Korea
Yeontae Jeong

Yeontae Jeong

Director of Upstream Development Group

Samsung Biologics
Korea
YoungMin-Oh_photo_profile

YoungMin Oh

Managing Director, Head of SMART Team

GI Innovation
Korea
Youngsun_Kim-updated

Youngsun Kim

Ph.D., Team Leader of MSAT 1

Samsung Biologics
Korea
Yang-Yuan-Sheng_photo_profile

Yuansheng Yang

Senior Principal Scientist, Group Leader, Cell Line Development

A*STAR
Singapore
Zhang-Wei_photo_profile

Zhang Wei

Principal Scientist, Group Leader, Downstream Processing

A*STAR Bioprocessing Technology Institute
Singapore
Zi Ying Zheng

Zi Ying Zheng

Senior Research Officer I- Downstream Processing, Bioprocessing Technology Institute

A*STAR
Singapore

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA/BIG PHARMA/ACADEMIC (ASIA)
Limited Super (By 18th November 2023)
SGD 1,495

Limited Special (By 2nd February 2024)
SGD 1,695 

Early Bird (By 1st March 2024)
SGD 1,895

Standard Price
SGD 2,095
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
BIOPHARMA/BIG PHARMA/ACADEMIC (OUTSIDE OF ASIA)
Limited Super (By 18th November 2023)
SGD 1,995

Limited Special (By 2nd February 2024)
SGD 2,195 

Early Bird (By 1st March 2024)
SGD 2,395

Standard Price
SGD 2,595
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
SOLUTION PROVIDER
Limited Super (By 18th November 2023)
SGD 3,795

Limited Special (By 2nd February 2024)
SGD 3,995 

Early Bird (By 1st March 2024)
SGD 4,095

Standard Price
SGD 4,295
Group Discount for Solution Providers & General Public: 
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off

FEATURED CONTENT

BMA24_Yaron-Silberberg-Interview
Exclusive Interview Video: Yaron R. Silberberg, Chief Scientist & Head of Customer Solution Center, Ajinomoto CELLiST Korea
BMA24_Judy-Chou-Interview
Exclusive Interview Video: Judy Chou, President and Chief Executive Officer, AltruBio Inc., USA
BMA24_Zhang-Wei-Interview
BMA 2024: Exclusive Interview with Dr Zhang Wei is a Senior Scientist, A*STAR in Singapore
MicrosoftTeams-image (58)
Biomanufacturing Content Insights Bundle
MicrosoftTeams-image (57)
Interview with Zhang Wei
Ebook-website-cover-900-x-480
Unveiling the Top 10 Phase 3 Pipelines and Collaboration Opportunities
BMA24
Top 5 China Biomanufacturing Trends in 2024
BMA24_Biomanufacturing-Facility-APAC-1 (1)
Biomanufacturing Facilities in APAC
greater_china
APAC Biopharma Directory & Overview
bio
[Ashutosh Sharma] Key Future Trends & Innovation Of Biologics Manufacturing In 2023
BMA-23-Ebook-cover-1500-x-1500-1024x1024
[Wolfram Carius] Key Future Trends & Innovation Of Biologics Manufacturing In 2023
BMA-23-Ebook-cover-1500-x-1500-1024x1024
[Jean-Francois Dierick] Key Future Trends & Innovation Of Biologics Manufacturing In 2023
BMA23-Ebook-cover-1500-x-1500-1-1024x1024
Singapore, The Next Asia Pacific BioMedical Hub
MicrosoftTeams-image-2022-08-05T090711.485
Explosion Of New Biologics Modalities
prospectus image biologics manufacturing asia
Sponsorship Prospectus
ABEA-Knowledge-Section
#ABEA2021 Winners
PRE CONFERENCE WORKSHOP: ADVANCE MANUFACTURING
  • 19th March 2024, Tuesday
  • 1:30 PM - 5:30 PM SGT
  • Sands Expo & Convention Center, Marina Bay Sands, Singapore

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.

CCO,  
Regional Commercial Director  

Cold Chain Technologies

BMA was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.

Ciaran O'Keeffe,  
Director Business Development & Channel Sales  

MasterControl

With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!

Senior,  
Technical Account Specialist  

West Pharmaceutical Services

Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.

Nick Kotlarski,  
President, VP of BioManufacturing  

Bioworkshops Limited

The conference was a great success and fruitful.

Cai Bao,  
VP of BioManufacturing  

Biocon

Fantastic conference with professional team.

Julio Lin,  
VP  

Blue Blood Biotech

Informative session. Exhibition was well targeted and diverse. Presenters shared latest development

Sankar Dharmaraj,  
Head, GMP Operations  

Hilman Laboratories

It was an awesome experience to interact with so many energetic young professionals around the globe and share technical information. I want to express my heartfelt gratitude to the organizer for such a great event!

MD Atiqur Rahman,  
Senior Executive Officer, Professional (Sterile)  

Incepta

It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!

Koh Wei Jet,  
Sanofi  

EVF Project Process Manufacturing Leader

Great forum for face to face interactions and for exchange of ideas and information.

Chris Lee,  
Site head, Singapore Development and Manufacturing  

WuXi Biologics

The entire event was managed flawlessly by the Organizers. I personally did not face any technical glitches despite this even was organized in a hybrid manner. Almost every speaker gave a high quality presentation which was very insightful.

Chandrakant Kathote,  
Site Head & Vice President  

Lupin Ltd

It was really great experience for me to be associated with IMAPAC which organizes high standard conference. Speakers from various domains/fields are thoughtfully chosen & they have delivered the relevant fields of present post-covid pandemic biologics scenario.

Dr. Swapan Kumar Jana,  
Director R&D and Manufacturing  

Serum Institute Of India Pvt. Limited

A well organized ambitious meeting. I hope it will continue to develop in the future.

Jean Francois Dierick,  
Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development  

GSK Vaccines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Apply For Speaking Opportunity

Download Featured Content Form

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter